Francois LELLOUCHE | Université Laval ...

Dr. Francois Lellouche, MD

Claim this profile

Institut Universitaire de Cardiologie et de Pneumologie de Québec

Studies Anoxemia
Studies Low Oxygen Levels
11 reported clinical trials
80 drugs studied

Affiliated Hospitals

Image of trial facility.
Institut Universitaire De Cardiologie Et De Pneumologie De Québec
Image of trial facility.
Institut Universitaire De Cardiologie Et De Pneumologie De Québec

Clinical Trials Francois Lellouche, MD is currently running

Image of trial facility.

FreeDom Strategy

for COPD Exacerbations

The main objective of the study is to assess the "FreeDom" innovative strategy (FreeO2 at Domicile) to reduce hospitalization duration in patients with COPD exacerbation. This strategy associates early hospital discharge, automated O2 flow weaning with FreeO2 system, telemedicine and tele-rehabilitation. The main hypothesis of this study is that the FreeDom strategy will reduce the number of hospitalization day by 50 percent at day 30.
Recruiting1 award N/A6 criteria
Image of trial facility.

Oximeter Comparison

for Low Oxygen Levels

The oximeter is used to monitor intensive care patients undergoing oxygen therapy. It indicates pulsed oxygen saturation (SpO2), a reflection of arterial oxygen saturation (SaO2) which enables detection of hypoxemia and hyperoxia, both deleterious state. Current SpO2 recommendations aim to reduce both risk of hypoxemia and hyperoxia. SpO2 is considered the 5th vital sign. Current recommendations for SpO2 targets do not consider the variability of oximeters used in clinical practice. This variability and lack of specification represent an obstacle to an optimal practice of oxygen therapy. Thus, this study aims to compare the SpO2 values of different oximeters (General Electric-GE, Medtronic, Masimo and Nonin) used in clinical practice with the SaO2 reference value obtained by an arterial gas in order to specify the precision and the systematic biases of the oximeters studied. This data will also make it possible to refine the recommendations concerning optimal oxygenation
Recruiting1 award N/A6 criteria

More about Francois Lellouche, MD

Clinical Trial Related7 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical Trials
Treatments Francois Lellouche, MD has experience with
  • Interferon Beta-1a
  • Placebo
  • Hydroxychloroquine
  • Vitamin C
  • Macrolide Administered For 3-5 Days
  • No Cysteamine

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Francois Lellouche, MD specialize in?
Is Francois Lellouche, MD currently recruiting for clinical trials?
Are there any treatments that Francois Lellouche, MD has studied deeply?
What is the best way to schedule an appointment with Francois Lellouche, MD?
What is the office address of Francois Lellouche, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security